BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03142334-completion@plaintrial.com
DTSTAMP:20261029T044831Z
DTSTART;VALUE=DATE:20260204
SUMMARY:Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy
  in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-34
 75-564/KEYNOTE-564) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03142334
URL:https://plaintrial.com/trial/NCT03142334
END:VEVENT
END:VCALENDAR